1072 related articles for article (PubMed ID: 17707010)
1. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
[TBL] [Abstract][Full Text] [Related]
2. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
[TBL] [Abstract][Full Text] [Related]
3. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
Martín-Crespo R; Luque R
Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
[TBL] [Abstract][Full Text] [Related]
4. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Radvanska E; Kovács L; Rittig S
J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
[TBL] [Abstract][Full Text] [Related]
5. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
6. The impact of attention deficit hyperactivity disorders on brainstem dysfunction in nocturnal enuresis.
Baeyens D; Roeyers H; Hoebeke P; Antrop I; Mauel R; Walle JV
J Urol; 2006 Aug; 176(2):744-8. PubMed ID: 16813934
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
8. Attention deficit-hyperactivity disorder symptoms and daytime voiding symptoms in children with primary enuresis: an observational study to evaluate the effectiveness of desmopressin treatment.
Yang TK; Guo YJ; Chang HC; Yang HJ; Huang KH
ScientificWorldJournal; 2015; 2015():356121. PubMed ID: 25866838
[TBL] [Abstract][Full Text] [Related]
9. A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder.
Gor RA; Fuhrer J; Schober JM
J Pediatr Urol; 2012 Jun; 8(3):314-7. PubMed ID: 21131234
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of attention deficit-hyperactivity disorder in children with nonmonosymptomatic nocturnal enuresis: a 4-year followup study.
Baeyens D; Roeyers H; Van Erdeghem S; Hoebeke P; Vande Walle J
J Urol; 2007 Dec; 178(6):2616-20. PubMed ID: 17945295
[TBL] [Abstract][Full Text] [Related]
12. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
[TBL] [Abstract][Full Text] [Related]
13. The effect of obesity on treatment efficacy in children with nocturnal enuresis and voiding dysfunction.
Guven A; Giramonti K; Kogan BA
J Urol; 2007 Oct; 178(4 Pt 1):1458-62. PubMed ID: 17706706
[TBL] [Abstract][Full Text] [Related]
14. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and treatment of enuresis.
Ramakrishnan K
Am Fam Physician; 2008 Aug; 78(4):489-96. PubMed ID: 18756657
[TBL] [Abstract][Full Text] [Related]
16. The effect of desmopressin on short-term memory in children with primary nocturnal enuresis.
Müller D; Florkowski H; Chavez-Kattau K; Carlsson G; Eggert P
J Urol; 2001 Dec; 166(6):2432-4. PubMed ID: 11696805
[TBL] [Abstract][Full Text] [Related]
17. Correlation between symptoms of voiding dysfunction and attention deficit disorder with hyperactivity in children with lower urinary tract symptoms.
Yang TK; Guo YJ; Chen SC; Chang HC; Yang HJ; Huang KH
J Urol; 2012 Feb; 187(2):656-61. PubMed ID: 22177910
[TBL] [Abstract][Full Text] [Related]
18. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis.
Dehoorne JL; Raes AM; van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2006 Aug; 176(2):754-7; discussion 757-8. PubMed ID: 16813936
[TBL] [Abstract][Full Text] [Related]
19. The impact of maturation of brainstem inhibition on enuresis: a startle eye blink modification study with 2-year followup.
Baeyens D; Roeyers H; Naert S; Hoebeke P; Vande Walle J
J Urol; 2007 Dec; 178(6):2621-5. PubMed ID: 17945294
[TBL] [Abstract][Full Text] [Related]
20. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.
Van Herzeele C; Alova I; Evans J; Eggert P; Lottmann H; Nørgaard JP; Vande Walle J
J Urol; 2009 Oct; 182(4 Suppl):2045-9. PubMed ID: 19695639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
